(April 17, 2020) The Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer brings together women’s healthcare professionals from across the globe to discuss the latest findings in gynecologic oncology. This … Continued
(April 15) The novel coronavirus, COVID-19, has become nearly all consuming. It’s impossible to turn on the news, browse social media, or walk outside without being reminded of the new, … Continued
There are many adjectives one can use to describe ovarian cancer: relentless, cruel, a monster. But Dr. Sunila Pradeep also finds it ironic. “Women spend a lot of time and … Continued
(April 9, 2020) Why do some gynecologic cancer patients participate in clinical trials, while others do not? Clinical trials are fundamental to the discovery of new and better therapies in … Continued
(April 7, 2020) In a study published last week in the oncology Journal of the American Medical Association, breastfeeding was found to be a factor for reduced risk of developing … Continued
Cockroaches after a nuclear war. That is really the best way to understand what Dr. Ugo Cavallaro, a cell biologist and biochemist, is working on in his lab in Milan, … Continued
(3/17/2020) Research out of the University of Bristol looked at genes and how they inhibit an enzyme involved in regulating the body’s cholesterol. This enzyme is the target of statin … Continued
She has swum in the Amazon, gone ice fishing in the Arctic, traveled the Galapagos, and hang-glided in New Zealand. But the biggest trail Dr. Beth Karlan has blazed throughout … Continued
Dr. Ron Buckanovich, an OCRA grantee, uses a metaphor to describe his work. “If I’m trying to get into Chicago and the highways that get me into the city are … Continued
What do the fur patterns of tigers have to do with advances in ovarian cancer treatment? Juan Cubillos-Ruiz, PhD, an OCRA grantee, grew up on a farm near Bogota, Colombia. … Continued
(February 13, 2020) PARP inhibitors have shown to be a promising treatment option for a subset of ovarian cancer patients. As of February 2020, there are currently 3 FDA-approved PARP … Continued
(January 15, 2020) A new study in the Journal of the American Medical Association (JAMA) found no statistically significant association between self-reported use of powder in the genital area and … Continued
Get email updates about research news, action alerts, and ways to join the fight.
